Nephrology Times
Advertisement
It is important to know the risks versus benefits of a reduced-dose methylprednisolone regimen in high-risk IgAN patients.
Patients with both IgAN and C2 lesions displayed a poor clinical prognosis requiring more effective treatment strategies.
The American Society of Nephrology has launched the Glomerular Diseases Collaborative.
There is a need to identify prognostic biomarkers of IgA nephropathy (IgAN) that can be used in clinical practice.
The CMMI renewed its contract with Phreesia to use the Patient Activation Measure to support the Kidney Care Choices Model.
Critical Financial Shifts Ahead: How CY 2025 ESRD PPS Changes Could Impact Small Dialysis Facilities
Sarah Tolson reviews the key financial implications of the CMS proposed rule for the ESRD Prospective Payment System.
The American Nephrology Nurses Association (ANNA) has launched a fellowship program to honor outstanding nephrology nurses.
RDNs can provide nutrition education and counseling for prevention and treatment of kidney stones.
34 Lives received a $44 million grant to support No Kidney Left Behind, a project to extend the viability of donated kidneys.
ASN Kidney Week 2024 early programs take place October 23 and offer the chance to earn continuing education credits.
Three posters related to Unicycive's drug candidates for kidney diseases will be presented at ASN Kidney Week 2024.
Research on xanthine oxidase activity in polycystic kidney disease sponsored by XORTX will be presented at ASN Kidney Week.
Michael Spigler of the American Kidney Fund spoke with Nephrology Times about the Unknown Causes of Kidney Disease Project.
Ajay Singh pays tribute to the late nephrologist and researcher Nicolaos Madias, MD, of Tufts Medical Center.
Having a precise estimation of the costs incurred by DKD patients is an important step in finding ways to contain such costs.
Researchers examined rates of incident dialysis and acute kidney injury among patients after heart failure hospitalization.
Researchers studied the feasibility of implementing a smartphone support tool for patients with both CKD and hypertension.
C-Path's Polycystic Kidney Disease Outcomes Consortium received a BAA award from the FDA, which will support ADTKD advances.
Anemia of CKD in China and its related health care costs are projected to rise, but earlier screening and treatment can help.
The ASN for the first time has issued guidance on the management of obesity in persons with kidney diseases.
Advertisement
630 Madison Ave.
Manalapan, NJ 07726
© 2024 Mashup Media, LLC. All rights reserved.